Agency Forms Undergoing Paperwork Reduction Act Review, 29087-29088 [2017-13414]
Download as PDF
<![CDATA[
29087
Federal Register / Vol. 82, No. 122 / Tuesday, June 27, 2017 / Notices
Exclusion
Studies published in languages other
than English.
Sharon B. Arnold,
Deputy Director.
[FR Doc. 2017–13394 Filed 6–26–17; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30 Day–17–0729]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Direct
written comments and/or suggestions
regarding the items contained in this
notice to the Attention: CDC Desk
Officer, Office of Management and
Budget, Washington, DC 20503 or by fax
to (202) 395–5806. Written comments
should be received within 30 days of
this notice.
Proposed Project
Customer Surveys Generic Clearance
for the National Center for Health
Statistics (0920–0729, Expiration 05/31/
2017)—Reinstatement—National Center
for Health Statistics (NCHS), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Section 306 of the Public Health
Service (PHS) Act (42 U.S.C. 242k), as
amended, authorizes that the Secretary
of Health and Human Services (DHHS),
acting through NCHS, shall collect
statistics on ‘‘the extent and nature of
illness and disability of the population
of the United States.’’ This is a
reinstatement request for a generic
approval from OMB to conduct
customer surveys over the next three
years at an overall burden rate of 4000
hours.
As part of a comprehensive program,
the National Center for Health Statistics
(NCHS) plans to continue to assess its
customers’ satisfaction with the content,
quality and relevance of the information
it produces. NCHS will conduct
voluntary customer surveys to assess
strengths in agency products and
services and to evaluate how well it
addresses the emerging needs of its data
users. Results of these surveys will be
used in future planning initiatives.
The data will be collected using a
combination of methodologies
appropriate to each survey. These may
include: Evaluation forms, mail surveys,
focus groups, automated and electronic
technology (e.g., email, Web-based
surveys), and telephone surveys.
Systematic surveys of several groups
will be folded into the program. Among
these are Federal customers and policy
makers, state and local officials who
rely on NCHS data, the broader
educational, research, and public health
community, and other data users.
Respondents may include data users
who register for and/or attend NCHS
sponsored conferences; persons who
access the NCHS Web site and the
detailed data available through it;
consultants; and others. Respondent
data items may include (in broad
categories) information regarding
respondent’s gender, age, occupation,
affiliation, location, etc., to be used to
characterize responses only. Other
questions will attempt to obtain
information that will characterize the
respondents’ familiarity with and use of
NCHS data, their assessment of data
content and usefulness, general
satisfaction with available services and
products, and suggestions for
improvement of surveys, services and
products.
In order to capture anticipated
additional feedback opportunities, this
reinstatement request allows for the
potential increase in both respondents
and time per response for a total
estimated annual burden total of 4,000
hours. There is no cost to respondents
other than their time to participate in
the survey. The resulting information
will be for NCHS internal use.
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondent
mstockstill on DSK30JT082PROD with NOTICES
Questionnaire for conference registrants/
attendees.
Focus groups ..................................................
Web-based ......................................................
Other customer surveys ..................................
VerDate Sep<11>2014
18:33 Jun 26, 2017
Number of
respondents
Form name
Jkt 241001
Public/private
others.
Public/private
others.
Public/private
others.
Public/private
others.
PO 00000
Frm 00066
Number of
responses per
respondent
Average
burden per
response
(hours)
researchers, Consultants, and
6,000
1
15/60
researchers, Consultants, and
500
1
1
researchers, Consultants, and
6,000
1
15/60
researchers, Consultants, and
2,000
1
15/60
Fmt 4703
Sfmt 4703
E:\FR\FM\27JNN1.SGM
27JNN1
29088
Federal Register / Vol. 82, No. 122 / Tuesday, June 27, 2017 / Notices
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
mstockstill on DSK30JT082PROD with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned subcommittee:
TIME AND DATE: 8:30 a.m.–3:30 p.m.,
EDT, August 11, 2017.
PLACE: CDC, Building 19, Rooms 245–
246, 1600 Clifton Road, NE., Atlanta,
Georgia 30329. This meeting will also be
held by teleconference.
STATUS: Open to the public, limited
only by the space available. The meeting
room accommodates approximately 20
people. The public is welcome to
participate during the public comment,
which is tentatively scheduled from
2:45 p.m. to 2:55 p.m., EDT. To
participate on the teleconference, please
dial 866–917–2712 and enter code
9418625.
PURPOSE: The Subcommittee will
provide advice to the ACD on strategies,
future needs, and challenges faced by
State, Tribal, Local and Territorial
health agencies, and will provide
guidance on opportunities for CDC
through the ACD.
MATTERS FOR DISCUSSION: The STLT
Subcommittee members will discuss
progress on implementation of ACDadopted recommendations related to the
health department of the future, other
emerging challenges and how CDC can
best support STLT health departments
in the transforming health system.
The agenda is subject to change as
priorities dictate.
CONTACT PERSON FOR MORE INFORMATION:
´
Jose Montero, MD, Designated Federal
Officer, STLT Subcommittee, ACD,
CDC, 4770 Buford Highway, MS E70,
Atlanta, GA 30341, Telephone (404)
498–0259, email: OSTLTSDirector@
cdc.gov. Please submit comments to
OSTLTSDirector@cdc.gov no later than
August 4, 2017.
Jkt 241001
National Institutes of Health
[FR Doc. 2017–13339 Filed 6–26–17; 8:45 am]
Advisory Committee to the Director
(ACD), Centers for Disease Control and
Prevention—State, Tribal, Local and
Territorial (STLT) Subcommittee
18:33 Jun 26, 2017
[FR Doc. 2017–13358 Filed 6–26–17; 8:45 am]
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2017–13414 Filed 6–26–17; 8:45 am]
VerDate Sep<11>2014
Dated: June 21, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Cancer
Biomarkers and Bio Specimens.
Date: July 27, 2017.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W264, Bethesda, MD 20892–9750
(Telephone Conference Call).
Contact Person: Reed A. Graves, Ph.D.,
Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W264, Bethesda, MD 20892–
9750 240–276–6384, gravesr@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; ‘‘Relationship
between Delirium and Alzheimer’s disease’’.
Date: July 21, 2017.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 2C223, 7201 Wisconsin
Ave., Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Isis S. Mikhail, MD, MPH,
DRPH, National Institute on Aging, Gateway
Building, 7201 Wisconsin Avenue, Suite
2C212, Bethesda, MD 20892, 301–402–7704,
Mikhaili@Mail.NIH.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: June 21, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–13360 Filed 6–26–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Disease; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
E:\FR\FM\27JNN1.SGM
27JNN1
]]>Agencies
[Federal Register Volume 82, Number 122 (Tuesday, June 27, 2017)]
[Notices]
[Pages 29087-29088]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-13414]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30 Day-17-0729]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) has submitted
the following information collection request to the Office of
Management and Budget (OMB) for review and approval in accordance with
the Paperwork Reduction Act of 1995. The notice for the proposed
information collection is published to obtain comments from the public
and affected agencies.
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address any of the following: (a)
Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility; (b) Evaluate the
accuracy of the agencies estimate of the burden of the proposed
collection of information, including the validity of the methodology
and assumptions used; (c) Enhance the quality, utility, and clarity of
the information to be collected; (d) Minimize the burden of the
collection of information on those who are to respond, including
through the use of appropriate automated, electronic, mechanical, or
other technological collection techniques or other forms of information
technology, e.g., permitting electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to omb@cdc.gov. Direct written comments
and/or suggestions regarding the items contained in this notice to the
Attention: CDC Desk Officer, Office of Management and Budget,
Washington, DC 20503 or by fax to (202) 395-5806. Written comments
should be received within 30 days of this notice.
Proposed Project
Customer Surveys Generic Clearance for the National Center for
Health Statistics (0920-0729, Expiration 05/31/2017)--Reinstatement--
National Center for Health Statistics (NCHS), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
Section 306 of the Public Health Service (PHS) Act (42 U.S.C.
242k), as amended, authorizes that the Secretary of Health and Human
Services (DHHS), acting through NCHS, shall collect statistics on ``the
extent and nature of illness and disability of the population of the
United States.'' This is a reinstatement request for a generic approval
from OMB to conduct customer surveys over the next three years at an
overall burden rate of 4000 hours.
As part of a comprehensive program, the National Center for Health
Statistics (NCHS) plans to continue to assess its customers'
satisfaction with the content, quality and relevance of the information
it produces. NCHS will conduct voluntary customer surveys to assess
strengths in agency products and services and to evaluate how well it
addresses the emerging needs of its data users. Results of these
surveys will be used in future planning initiatives.
The data will be collected using a combination of methodologies
appropriate to each survey. These may include: Evaluation forms, mail
surveys, focus groups, automated and electronic technology (e.g.,
email, Web-based surveys), and telephone surveys. Systematic surveys of
several groups will be folded into the program. Among these are Federal
customers and policy makers, state and local officials who rely on NCHS
data, the broader educational, research, and public health community,
and other data users. Respondents may include data users who register
for and/or attend NCHS sponsored conferences; persons who access the
NCHS Web site and the detailed data available through it; consultants;
and others. Respondent data items may include (in broad categories)
information regarding respondent's gender, age, occupation,
affiliation, location, etc., to be used to characterize responses only.
Other questions will attempt to obtain information that will
characterize the respondents' familiarity with and use of NCHS data,
their assessment of data content and usefulness, general satisfaction
with available services and products, and suggestions for improvement
of surveys, services and products.
In order to capture anticipated additional feedback opportunities,
this reinstatement request allows for the potential increase in both
respondents and time per response for a total estimated annual burden
total of 4,000 hours. There is no cost to respondents other than their
time to participate in the survey. The resulting information will be
for NCHS internal use.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Form name Number of responses per per response
respondents respondent (hours)
----------------------------------------------------------------------------------------------------------------
Questionnaire for conference Public/private 6,000 1 15/60
registrants/attendees. researchers,
Consultants, and others.
Focus groups.......................... Public/private 500 1 1
researchers,
Consultants, and others.
Web-based............................. Public/private 6,000 1 15/60
researchers,
Consultants, and others.
Other customer surveys................ Public/private 2,000 1 15/60
researchers,
Consultants, and others.
----------------------------------------------------------------------------------------------------------------
[[Page 29088]]
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2017-13414 Filed 6-26-17; 8:45 am]
BILLING CODE 4163-18-P
